1ZJ2 image
Entry Detail
PDB ID:
1ZJ2
Keywords:
Title:
Crystal Structure of Human Galactosyltransferase (GTB) Complexed with H type I Trisaccharide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2005-04-27
Release Date:
2005-12-13
Method Details:
Experimental Method:
Resolution:
1.69 Å
R-Value Free:
0.23
R-Value Work:
0.20
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
Chain IDs:A
Chain Length:293
Number of Molecules:1
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_900049
Primary Citation
Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases.
J.Biol.Chem. 281 3625 3632 (2006)
PMID: 16326711 DOI: 10.1074/jbc.M507620200

Abstact

The human ABO(H) blood group A and B antigens are generated by the homologous glycosyltransferases A (GTA) and B (GTB), which add the monosaccharides GalNAc and Gal, respectively, to the cell-surface H antigens. In the first comprehensive structural study of the recognition by a glycosyltransferase of a panel of substrates corresponding to acceptor fragments, 14 high resolution crystal structures of GTA and GTB have been determined in the presence of oligosaccharides corresponding to different segments of the type I (alpha-l-Fucp-(1-->2)-beta-D-Galp-(1-->3)-beta-D-GlcNAcp-OR, where R is a glycoprotein or glycolipid in natural acceptors) and type II (alpha-l-Fucp-(1-->2)-beta-D-Galp-(1-->4)-beta-d-GlcNAcp-OR) H antigen trisaccharides. GTA and GTB differ in only four "critical" amino acid residues (Arg/Gly-176, Gly/Ser-235, Leu/Met-266, and Gly/Ala-268). As these enzymes both utilize the H antigen acceptors, the four critical residues had been thought to be involved strictly in donor recognition; however, we now report that acceptor binding and subsequent transfer are significantly influenced by two of these residues: Gly/Ser-235 and Leu/Met-266. Furthermore, these structures show that acceptor recognition is dominated by the central Gal residue despite the fact that the L-Fuc residue is required for efficient catalysis and give direct insight into the design of model inhibitors for GTA and GTB.

Legend

Protein

Chemical

Disease

Primary Citation of related structures